Glucovia (Sitagliptin 100 mg Tablets)

Glucovia (Sitagliptin 100 mg Tablets)

Product Showcase
Glucovia (Sitagliptin 100 mg Tablets)
Glucovia (Sitagliptin 100 mg Tablets)

Information

A pharmaceutical product containing Sitagliptin, a DPP-4 inhibitor approved for the treatment of type 2 diabetes mellitus. -Sitagliptin 100 mg film-coated tablet -Manufactured under PIC/S GMP standards -Bioequivalence (BE) study completed -eCTD dossier available
Bangkok Lab and Cosmetic Public Company LimitedK02Bangkok Lab and Cosmetic Public Company Limited (BLC) is a healthcare solutions group specializing in pharmaceuticals, herbal medicines, supplements, cosmetics, medical devices, and OEM/CDMO services. Backed by integrated R&D, PIC/S GMP manufacturing facilities, and ISO/IEC 17025 accredited laboratories, BLC is committed to delivering innovative, high-quality healthcare solutions while creating long- term value as well as sustainable growth

Log in

See all the content and easy-to-use features by logging in or registering!